Market Size (2015)
2015
$11.90B
Healthcare
Chlorhexidine Gluconate CHG Cloth Market
By Segment, By Region, And Segment Forecasts, 2015 – 2023
Vertical: HealthcareBase Year: 201711 Sections
Executive Summary
Chlorhexidine Gluconate CHG Cloth Market — Snapshot
Projected (2023)
2023
$16.47B
CAGR (2015–2023)
4.1%
4.1%Key Players
109+
Surgical site infections or SSI are common surgical complications. Chlorhexidine gluconate (CHG) cloths are premoistened with an FDA-approved antiseptic solution to help reduce bacteria on the skin before surgery. The rinse-free formula stays on the skin and is trusted by nurses to help reduce the risk of developing an SSI. Rising surgical site infections and a strong recommendation for the use of CHG products as an antiseptic agent by authorized healthcare organizations have led to the growth of the global chlorhexidine gluconate (CHG) cloth market in the recent years. However, side-effects of CHG are likely to restrain the market growth over the forecast period.
The global chlorhexidine gluconate (CHG) cloth market is growing at a rapid pace and is projected to reach USD 16,469.14 thousand by 2023 from USD 13,167.00 thousand in 2017 at a CAGR of 3.80% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with a 48.70% share, followed by Europe and Asia-Pacific with shares of 28.41% and 16.57%, respectively.
The market has been segmented based on product, CHG concentration, application, and distribution channel.
The global chlorhexidine gluconate (CHG) cloth market has been segmented, based on product, CHG impregnated cloth, and CHG compatible/non-impregnated cloth. Based on product, the CHG impregnated cloth segment accounted for the largest market share of 64.28% in 2017, with a market value of USD 8,463.21 thousand, and is projected to register a CAGR of 4.32% during the forecast period. The CHG compatible/non-impregnated cloth segment accounted for a market share of 35.72% in 2017, with a market value of USD 4,703.79 thousand, which is projected to register a CAGR of 2.82% during the forecast period.
The global chlorhexidine gluconate (CHG) cloth market, based on CHG concentration, has been segmented into 2% chlorhexidine gluconate cloth and 4% chlorhexidine gluconate cloth. Based on CHG concentration, the 2% chlorhexidine gluconate cloth segment accounted for the larger market share of 75.77% in 2017, with a market value of USD 9,976.47 thousand, which is projected to register a CAGR of 4.22% during the forecast period. The 4% chlorhexidine gluconate cloth segment is projected to register a 24.23% CAGR during the forecast period and accounted for USD 3,190.53 thousand in 2017.
The global chlorhexidine gluconate (CHG) cloth market, based on application, has been segmented into surgical preparation and personal care. Based on application, the surgical preparation segment accounted for the larger market share of 76.15% in 2017, with a market value of USD 10,027.16 thousand, which is projected to register a CAGR of 4.22% during the forecast period. The personal care segment is projected to register a 23.85% CAGR during the forecast period and accounted for USD 3,139.84 thousand in 2017.
The global chlorhexidine gluconate (CHG) cloth market, based on distribution channel, has been segmented into hospital and retail pharmacies and online platforms. Based on distribution channel, the hospital and retail pharmacies segment accounted for the larger market share of 57.02% in 2017, with a market value of USD 7,507.56 thousand, which is projected to register a CAGR of 3.90% during the forecast period. The online platforms segment is projected to register a 42.98% CAGR during the forecast period and accounted for USD 5,659.44 thousand in 2017.
Key Insight
The Chlorhexidine Gluconate CHG Cloth Market market is projected to grow at a CAGR of 4.1% from 2015 to 2023.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 5 regions: South America, North America, Europe, Asia Pacific, Middle East and Africa.
- Market Segmentation: The market is analyzed across 2 segments: CHG Impregnated Cloth, CHG Non Impregnated Cloth. Forecasts are provided for each segment from 2015 to 2023.
- Competitive Landscape: 109 leading companies are profiled, covering market positioning, strategies, and recent developments.
Market Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
Chlorhexidine Gluconate CHG Cloth Market — Growth Trajectory
The scope of the global chlorhexidine gluconate (CHG) cloth market study includes the market size analysis and a detailed analysis of the manufacturers’ products and strategies. The market is further segmented based on product, application, distribution channel, and region.
Chlorhexidine Gluconate CHG Cloth Market — Growth Trajectory
CHG Impregnated Cloth
CHG Non Impregnated Cloth
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size Trend (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- Product Product is broken down into: CHG Impregnated Cloth, CHG Non Impregnated Cloth.
- CHG Concentration CHG Concentration is broken down into: 2 percent CHG Cloth, 4 percent CHG Cloth.
- Application Application is broken down into: Surgical Preparation, Personal Care.
- Distribution Channel Distribution Channel is broken down into: Hospital and Retail Pharmacies, Online Platforms.
Geographic Analysis
Regional market breakdown
- South America South America market size reached $1.05B in 2015 and is projected to reach $1.23B by 2023, growing at a CAGR of 2.0%.
- North America North America market size reached $4.74B in 2015 and is projected to reach $6.73B by 2023, growing at a CAGR of 4.5%.
- Europe Europe market size reached $3.38B in 2015 and is projected to reach $4.60B by 2023, growing at a CAGR of 3.9%.
- Asia Pacific Asia Pacific market size reached $1.96B in 2015 and is projected to reach $2.99B by 2023, growing at a CAGR of 5.4%.
- Middle East and Africa Middle East and Africa market size reached $773.34M in 2015 and is projected to reach $919.85M by 2023, growing at a CAGR of 2.2%.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
Chlorhexidine Gluconate CHG Cloth Market — How We Researched This Market
This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2017
Historical Period
2015 – 2017
Forecast Period
2017 – 2023
Primary Interviews
150+
Research Process
Historical data (2015–2017) and forecast period (2017–2023)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Historical vs. Forecast Data
Historical (observed)
Forecast (modelled)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCompetitive Landscape & Porter's Five Forces
Chlorhexidine Gluconate CHG Cloth Market — Competitive Analysis
Bargaining Power of Suppliers
The traders in the global chlorhexidine gluconate (CHG) cloth industries are developers and producers of chlorhexidine gluconate (CHG) cloths. Currently, limited suppliers are present in the market due to a large number of substitutes present. In addition, chlorhexidine gluconate (CHG) cloth have stringent rules and regulation regarding its usage. Few prevailing key companies capture significant share in the global market and have the capability of fluctuating the costs of the technologies. The overall bargaining power of suppliers in the global chlorhexidine gluconate (CHG) cloth market is high, as suppliers are limited, and buyers are left with limited options.
Bargaining Power of Buyers
The bargaining power of the buyers is medium to high in the global chlorhexidine gluconate (CHG) cloth market due to the existence of a huge number of buyers in the industry. There is a huge number of buyers in the market which includes hospitals and clinics, the pharmaceutical industry, specialty centers, etc. Growing population, high demand and price consciousness of buyer affects their bargaining power in the market.
Threat of New Entrants
The threat of new entrants is medium to high in the global chlorhexidine gluconate (CHG) cloth market. In the case of chlorhexidine gluconate (CHG) cloth industry, the only thing stopping new growers from entering the market is the approval required by the government. The chlorhexidine gluconate (CHG) cloth market is also characterized by a moderate degree of brand loyalty. Additionally, government support and the presence of huge opportunities in the market as more states are legalizing the production of chlorhexidine gluconate (CHG) cloth have encouraged many players to invest in this lucrative market.
Threat of Substitutes
The threat of substitutes in the global chlorhexidine gluconate (CHG) cloth market is low because of the advantages that chlorhexidine gluconate (CHG) wipes offer in the reduction of hospital-acquired infections. This gives the buyers a choice to choose. Conclusively, it can be said that the threat of substitute persists in the market, developing a low risk of substitute for the players in the chlorhexidine gluconate (CHG) cloth market.
Intensity of Rivalry
The degree of competition in the global chlorhexidine gluconate (CHG) cloth market is medium to high. Introduction of the newer products is increasing the intensity of rivalry in the market. Chlorhexidine gluconate (CHG) cloth manufacturing companies are trying to develop products with high quality and improved safety to increase the demand for chlorhexidine gluconate (CHG) cloth.
Quantitative Analysis
Regional Breakdown
Regional market breakdown for Chlorhexidine Gluconate CHG Cloth Market.
Regional Market Size (USD Mn)
Market estimates by geography (2023)
USD Mn
InsightNorth America leads with $6.73B by 2023, while Asia Pacific is projected to grow fastest at a 5.4% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRegional Market Data
| REGION | 2015 | 2017 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| South America | $1.05B | $1.16B | $1.23B | 2.0% | 7% |
| North America | $4.74B | $5.75B | $6.73B | 4.5% | 41% |
| Europe | $3.38B | $4.02B | $4.60B | 3.9% | 28% |
| Asia Pacific | $1.96B | $2.39B | $2.99B | 5.4% | 18% |
| Middle East and Africa | $773.34M | $869.73M | $919.85M | 2.2% | 6% |
| Total | $11.90B | $14.19B | $16.47B | 4.1% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSegment Revenue (2023)
CHG Impregnated Cloth
CHG Non Impregnated Cloth
030006001900112001
Segment Market Share
- CHG Impregnated Cloth66%
- CHG Non Impregnated Cloth34%
Total Market Size
$16.47B
Market by Segment (2023)
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| CHG Impregnated Cloth | $10.91B | 4.1% | 81% |
| CHG Non Impregnated Cloth | $5.56B | 4.1% | 46% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansEmpower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
Chlorhexidine Gluconate CHG Cloth Market — Key Findings
Analytical insights on Chlorhexidine Gluconate CHG Cloth Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
The Chlorhexidine Gluconate CHG Cloth Market market is projected to reach $16.47B by 2023, growing at 4.1% CAGR. The CHG Impregnated Cloth segment holds the largest share.
Market Dynamics
Chlorhexidine gluconate (CHG) cloths are premoistened antiseptic cloths used as cleaning agents. These cloths are used for prepping the skin before surgery to prevent or reduce bacterial infections. CHG cloth is the easiest and convenient method adopted by hospitals and surgeons to reduce surgical site infections (SSI).
The CHG cloth market is driven by rising surgical site infections, stringent guidelines to use antiseptic agents to reduce infections, increasing cases of nosocomial infection, development in pharmaceutical and biotechnology industries, and raising awareness about the CHG cloth. However, strict government regulations, side-effects of CHG, and standardization methods related to the CHG cloth could hamper market growth.
Market Drivers
Surgical site infections (SSI) are considered as a major burden to patients and also for health care organizations. The Safe Care Campaign states that in surgical patients 38% of all nosocomial infections are caused due to surgical site infections.
There are various antiseptic solutions and products recommended under the surgical safety guidelines which are available in the market. According to the Centers for Disease Control (CDC) guidelines for the inhibition of surgical site infections, it is recommended, that patients should take a bath with antiseptic agents such as CHG products. It was also reported that the US Food and Drug Administration (FDA) had approved antiseptic skin products such as 4% Chlorhexidine Gluconate (CHG) solution and an alcohol-free 2% CHG impregnated no-rinse cloth.
The Massachusetts Health & Hospital Association publication reported that there is a high risk of healthcare-acquired infections (HAI). The Centers for Disease Control (CDC) estimated 1.7 thousand people are suffering from healthcare-acquired infections each year in American hospitals. Of these healthcare-acquired infections, 32% are urinary tract infections,22% are surgical site infections and other related infections.
This huge population affected with healthcare-acquired infections is increasing the demand for Chlorhexidine Gluconate (CHG) cloths while surgery and contributing to enhance the CHG cloth market.
Market Opportunities
Developing regions such as China, India, and Japan have evolved as a cost-effective manufacturing platform for the CHG cloth market. Due to the availability of raw materials at affordable cost, low labor charges, and low transportation cost compared to developed nations, developing regions act as the best opportunity for the CHG cloth market. Also, moderate government regulations in developing regions promote to establish business and manufacturing units. These various suitable facilities provided by developing nations promote investors to initiate business in these regions.
Market Restraints
Along with its medical applications, the CHG product has some side-effects and unwanted reactions on the skin. In some patients, the use of the Chlorhexidine Gluconate (CHG) cloth may cause skin problems such as the burning of skin, blisters, itching, peeling, redness, skin rash, swelling, or other signs of irritation on the face, hands, and other parts of the body. The US Food and Drug Administration (FDA): Drug Safety Commotion 2017, reported that the use of CHG product might cause rare but serious allergic reactions to the skin. These reactions could take place within minutes of exposure to chlorhexidine gluconate. The serious allergic reactions include difficulty in breathing, swelling of the face, shock, and other life-threatening conditions that occur when the body is not getting enough blood flow. However, side-effects associated with the use of CHG products may affect the demand and use among the patient population which may result to hamper market growth.
Strategic Outlook and Future Directions
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Market Value by Segment (2023)
Value (USD Mn)
CHG Impregnated Cloth
CHG Non Impregnated Cloth
Companies
Key companies profiled in Chlorhexidine Gluconate CHG Cloth Market
Profiles of 109 companies operating in the Chlorhexidine Gluconate CHG Cloth Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Mölnlycke
Mölnlycke Health Care AB
Healthcare
Company Headquarters: Sweden Founded: 1849 Workforce: 7,760 Company Working: Mölnlycke Health Care AB develops and manufactures single-use surgical and wound care products for customers, healthcare professionals, and patients internationally. It offers wound care systems, antiseptics, customized procedure trays, dermatology/scar treatment products, dental/stoma/tracheostomy, support/compression products, surgical drapes, surgical gloves, surgical staff clothing, wound care dressings, and wound care supplementary products for angiographic procedures, cardiovascular surgery, ear, nose and throat (ENT) surgery, and others.
Revenue$1.5B
Employees7,760
Market CapN/A
Founded1848
Sweden
Medline In
Medline Industries Inc.
Healthcare
Company Headquarters: Northfield, IL Founded: 1966 Workforce: 15,000 Company Working: Medline Industries Inc. is the largest privately held manufacturer and distributor of medical supplies and is uniquely positioned to provide products, education, and support across the continuum of care. Its ability is to bring best practices from one care setting to another from large healthcare systems and independent physicians’ practices to patients and their families.
RevenueN/A
Employees15,000
Market CapN/A
Founded1965
Northfield, IL
GAMA Healt
GAMA Healthcare Ltd
Healthcare
Company Headquarters: Hertfordshire, UK Founded: 2004 Workforce: 51-200 Company Working: GAMA Healthcare Ltd is a dynamic, innovative company specializing in manufacturing and distributing unique, quality products within the healthcare industry.
RevenueN/A
Employees200
Market CapN/A
Founded2003
Hertfordshire, UK
Clinicept
Clinicept Healthcare Ltd
Healthcare
Company Headquarters: Harrogate, UK Company Working: Clinicept Healthcare Ltd is involved in developing and manufacturing healthcare products which are used for cleanliness purposes. Patient care and hygiene and surface disinfection are two major segments the company focuses. The surface disinfection product range includes alcohol-free disinfectant wipes, isopropyl alcohol (IPA) disinfectant wipes, hand and surface sanitizing wipes, and also disinfectant wipes used to clean medical devices. Under patient care and hygiene, the company provides rinse-free shampoo caps, bed bath wipes, and hand and face patient wipes. In addition to these products, the company also provides patient care wipes, which are macerator friendly.
RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
Harrogate, UK
Cardinal H
Cardinal Health
Healthcare
Company Headquarters: Ohio, US Founded: 1971 Workforce: ~50,000 Company Working: Cardinal Health is a global, integrated healthcare services and products company. The firm provides customized solutions for hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physicians’ offices worldwide. It operates through two business segments, namely, medical products and pharmaceuticals. Through these segments, it offers cost-effective solutions that enhance the supply chain efficiency from hospital to home. It connects patients, providers, payers, pharmacists, and manufacturers for integrated care coordination and better patient management. Through its services and products, it serves nearly 85% of hospitals, more than 26,000 pharmacies, and more than 10,000 specialty physician offices and clinics across the US. In the fiscal year 2018, nearly 50,000 global employees operated in more than 46 countries.
Revenue$121.5B
Employees50,000
Market CapN/A
Founded1970
Ohio, US
Stryker
Stryker
Healthcare
Company Headquarters: Michigan, US Founded: 1941 Workforce: ~51,000 Company Working: Stryker is engaged in developing, manufacturing, and marketing specialty surgical and medical products. Its products include implants, biologics, surgical, neurologic, ear, throat, interventional pain equipment, endoscopic, surgical navigation, communications, and digital imaging systems. The company also offers products for patient handling and emergency medical equipment. It operates through three major segments: medical & surgical equipment (MedSurg), orthopedics, and neurotechnology & spine. Stryker has been focused on providing automation solutions in its product portfolio. It has a presence in over 75 countries across the globe.
Revenue$11.3B
Employees51,000
Market CapN/A
Founded1940
Michigan, US
Page 1 of 19
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Chlorhexidine Gluconate CHG Cloth Market
Starting from
$4,950